StemRIM (TYO:4599)
Japan · Delayed Price · Currency is JPY 143.00
-5.00 (-3.38%)
Oct 26, 2026, 3:30 PM JST
StemRIM Market Cap
StemRIM has a market cap or net worth of 8.96 billion as of October 26, 2026. It is the 29,082nd most valuable company in the world and the 2,597th biggest in Japan. Its market cap has decreased by 50.43% in one year.
Market Cap
8.96B
Enterprise Value
3.59B
Revenue
n/a
Global Rank
Country Rank
#2,597 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 9, 2019, StemRIM's market cap has decreased from 49.82B to 8.96B, a decrease of -82.01%. That is a compound annual growth rate of -21.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 8.96B | -45.63% |
| Dec 30, 2025 | 16.49B | -15.37% |
| Dec 30, 2024 | 19.48B | -45.16% |
| Dec 29, 2023 | 35.52B | -34.08% |
| Dec 30, 2022 | 53.89B | 3.59% |
| Dec 30, 2021 | 52.02B | 40.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnGes | 11.57B |
| Kubota Pharmaceutical Holdings | 9.57B |
| Immuno-Biological Laboratories | 9.34B |
| Carna Biosciences | 8.18B |
| K Pharma,Inc. | 7.90B |
| Kidswell Bio | 7.54B |
| CellSeed | 7.46B |
| J-Pharma | 7.35B |